FGFR3 and bladder transitional cell carcinoma: The OS trend in lung adenocarcinoma patients though is similar to bladder urothelial carcinomas and skin cutaneous melanoma patients, but not to head and neck cancer and lung squamous carcinoma patients, based on our analysis using cBioPortal for survival of patients harboring activating FGFR3 mutations in different cancers (supplementary Figure S8, available at Annals of Oncology online).